Humana (NYSE:HUM – Get Free Report) had its price objective cut by investment analysts at Royal Bank of Canada from $400.00 to $265.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has an “outperform” rating on the insurance provider’s stock. Royal Bank of Canada’s price objective points to a potential […]

Ovintiv (NYSE:OVV – Free Report) had its price objective lowered by Citigroup from $58.00 to $55.00 in a research note released on Monday, Marketbeat reports. The firm currently has a buy rating on the stock. Other equities analysts have also issued reports about the stock. UBS Group lowered their price target on shares of Ovintiv […]

IQVIA (NYSE:IQV – Get Free Report) had its price target dropped by research analysts at Evercore ISI from $270.00 to $265.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm presently has an “outperform” rating on the medical research company’s stock. Evercore ISI’s target price would indicate a potential […]

Brinker International (NYSE:EAT – Get Free Report) had its target price upped by equities researchers at Citigroup from $69.00 to $83.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the restaurant operator’s stock. Citigroup’s target price would indicate a potential upside of 0.04% from the stock’s […]

RTX (NYSE:RTX – Get Free Report) had its price objective upped by equities researchers at Citigroup from $122.00 to $132.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Citigroup’s price objective suggests a potential upside of 7.71% from the company’s […]

Veeva Systems Inc. (NYSE:VEEV – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-four brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and sixteen have issued a buy recommendation on the company. […]

TD Cowen lowered shares of Humana (NYSE:HUM – Free Report) from a buy rating to a hold rating in a report issued on Monday, MarketBeat Ratings reports. TD Cowen currently has $261.00 target price on the insurance provider’s stock, down from their previous target price of $402.00. A number of other research analysts have also […]